Actively Recruiting

Phase 3
Age: 5Years - 17Years
All Genders
NCT05835310

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Led by AstraZeneca · Updated on 2026-05-06

100

Participants Needed

98

Research Sites

303 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Efficacy, and Safety of Anifrolumab in Children with Moderate to Severe Active Systemic Lupus Erythematosus (SLE)

CONDITIONS

Official Title

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Who Can Participate

Age: 5Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Parent or legal guardian and participant able to give informed consent/assent as required
  • Diagnosis of systemic lupus erythematosus per 2019 criteria for at least 3 months before consent
  • No signs or symptoms of active tuberculosis and no recent TB exposure without treatment
  • Negative pregnancy tests for females of childbearing potential at screening and randomization
  • Adherence to contraception methods by females of childbearing potential and males
Not Eligible

You will not qualify if you...

  • Diagnosis of interferon-mediated autoinflammatory interferonopathy
  • History or current significant non-SLE vasculitis
  • For participants 11 years and older: history or signs of suicidal ideation
  • Use of corticosteroids for non-SLE disease over 2 weeks within 24 weeks before consent
  • Positive HIV test
  • Active hepatitis B or C infection or recent Herpes Zoster infection
  • Ongoing cytomegalovirus or Epstein-Barr virus infection within 12 weeks before consent
  • History of severe COVID-19 infection requiring hospitalization or unresolved symptoms
  • Prior use of anifrolumab
  • Treatment with B-cell depleting agents like rituximab within 26 weeks before consent
  • Blood transfusion or blood products (except albumin) within 4 weeks before consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 98 locations

1

Research Site

Phoenix, Arizona, United States, 85016

Actively Recruiting

2

Research Site

Los Angeles, California, United States, 90027

Actively Recruiting

3

Research Site

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

4

Research Site

Chicago, Illinois, United States, 60611

Actively Recruiting

5

Research Site

Chicago, Illinois, United States, 60637

Actively Recruiting

6

Research Site

New Orleans, Louisiana, United States, 70118

Not Yet Recruiting

7

Research Site

Bethesda, Maryland, United States, 20889

Withdrawn

8

Research Site

Saint Paul, Minnesota, United States, 55125

Actively Recruiting

9

Research Site

New Hyde Park, New York, United States, 11042

Actively Recruiting

10

Research Site

New York, New York, United States, 10032

Actively Recruiting

11

Research Site

The Bronx, New York, United States, 10467

Actively Recruiting

12

Research Site

Valhalla, New York, United States, 10595

Actively Recruiting

13

Research Site

Durham, North Carolina, United States, 27710

Actively Recruiting

14

Research Site

Cincinnati, Ohio, United States, 45229

Actively Recruiting

15

Research Site

Cleveland, Ohio, United States, 44109

Actively Recruiting

16

Research Site

Columbus, Ohio, United States, 43203

Actively Recruiting

17

Research Site

Portland, Oregon, United States, 97227

Actively Recruiting

18

Research Site

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

19

Research Site

Greenville, South Carolina, United States, 29605

Withdrawn

20

Research Site

El Paso, Texas, United States, 79902

Actively Recruiting

21

Research Site

Houston, Texas, United States, 77030

Actively Recruiting

22

Research Site

Salt Lake City, Utah, United States, 84108

Actively Recruiting

23

Research Site

Buenos Aires, Argentina, C1270

Withdrawn

24

Research Site

Córdoba, Argentina, 5000

Actively Recruiting

25

Research Site

Rosario, Argentina, S2000PBJ

Actively Recruiting

26

Research Site

San Miguel de Tucumán, Argentina, T4000AXL

Not Yet Recruiting

27

Research Site

Porto Alegre, Brazil, 90035-903

Actively Recruiting

28

Research Site

Ribeirão Preto, Brazil, 14048-900

Actively Recruiting

29

Research Site

São Paulo, Brazil, 04024-002

Actively Recruiting

30

Research Site

São Paulo, Brazil, 05403 000

Actively Recruiting

31

Research Site

Calgary, British Columbia, Canada, T2N 4N1

Not Yet Recruiting

32

Research Site

Vancouver, British Columbia, Canada, V6H 3N1

Actively Recruiting

33

Research Site

Toronto, Ontario, Canada, M5G 1X8

Actively Recruiting

34

Research Site

Beijing, China, 100020

Withdrawn

35

Research Site

Beijing, China, 100032

Not Yet Recruiting

36

Research Site

Beijing, China, 100730

Actively Recruiting

37

Research Site

Changchun, China, 130021

Actively Recruiting

38

Research Site

Changsha, China, 410007

Actively Recruiting

39

Research Site

Nanjing, China, 210008

Not Yet Recruiting

40

Research Site

Shanghai, China, 201102

Actively Recruiting

41

Research Site

Suzhou, China, 215002

Actively Recruiting

42

Research Site

Wenzhou, China, 325027

Actively Recruiting

43

Research Site

Zhengzhou, China, 450018

Actively Recruiting

44

Research Site

Barranquilla, Colombia, 01800

Actively Recruiting

45

Research Site

Medellín, Colombia, 050034

Withdrawn

46

Research Site

Bordeaux, France, 33076

Actively Recruiting

47

Research Site

Bron, France, 69677

Actively Recruiting

48

Research Site

Le Kremlin-Bicêtre, France, 94275

Actively Recruiting

49

Research Site

Lille, France, 59037

Actively Recruiting

50

Research Site

Toulouse, France, 31300

Actively Recruiting

51

Research Site

Berlin, Germany, D-13353

Actively Recruiting

52

Research Site

Freiburg im Breisgau, Germany, 79106

Actively Recruiting

53

Research Site

Sankt Augustin, Germany, 53757

Actively Recruiting

54

Research Site

Genova, Italy, 16148

Actively Recruiting

55

Research Site

Milan, Italy, 20122

Actively Recruiting

56

Research Site

Milan, Italy, 20122

Not Yet Recruiting

57

Research Site

Padova, Italy, 35128

Actively Recruiting

58

Research Site

Roma, Italy, 00165

Actively Recruiting

59

Research Site

Bunkyō City, Japan, 113-8519

Actively Recruiting

60

Research Site

Bunkyō City, Japan, 113-8603

Actively Recruiting

61

Research Site

Chiba, Japan, 266-0007

Actively Recruiting

62

Research Site

Fuchu-shi, Japan, 183-8561

Actively Recruiting

63

Research Site

Kawasaki-shi, Japan, 216-8511

Actively Recruiting

64

Research Site

Kobe, Japan, 650-0047

Actively Recruiting

65

Research Site

Obu-shi, Japan, 474-8710

Actively Recruiting

66

Research Site

Shinjuku-ku, Japan, 162-8666

Actively Recruiting

67

Research Site

Yokohama, Japan, 232 8555

Actively Recruiting

68

Research Site

Yokohama, Japan, 236-0004

Actively Recruiting

69

Research Site

Atizapán de Zaragoza, Mexico, 52937

Not Yet Recruiting

70

Research Site

Guadalajara, Mexico, 44620

Actively Recruiting

71

Research Site

Mérida, Mexico, 97070

Actively Recruiting

72

Research Site

México, Mexico, 06720

Actively Recruiting

73

Research Site

Monterrey, Mexico, 64460

Actively Recruiting

74

Research Site

Lodź, Poland, 91-738

Actively Recruiting

75

Research Site

Warsaw, Poland, 02-637

Actively Recruiting

76

Research Site

Wroclaw, Poland, 52-114

Actively Recruiting

77

Research Site

Lisbon, Portugal, 1169-045

Withdrawn

78

Research Site

Lisbon, Portugal, 1649-035

Withdrawn

79

Research Site

Porto, Portugal, 4200-319

Withdrawn

80

Research Site

Cape Town, South Africa, 7700

Withdrawn

81

Research Site

Esplugues de Llobregat, Spain, 8950

Actively Recruiting

82

Research Site

Madrid, Spain, 28009

Actively Recruiting

83

Research Site

Madrid, Spain, 28034

Actively Recruiting

84

Research Site

Madrid, Spain, 28046

Not Yet Recruiting

85

Research Site

Málaga, Spain, 29011

Actively Recruiting

86

Research Site

Santiago de Compostela, Spain, 15706

Not Yet Recruiting

87

Research Site

Valencia, Spain, 46026

Actively Recruiting

88

Research Site

Ankara, Turkey (Türkiye), 06230

Actively Recruiting

89

Research Site

Istanbul, Turkey (Türkiye), 34098

Actively Recruiting

90

Research Site

Kayseri, Turkey (Türkiye), 38039

Actively Recruiting

91

Research Site

Umraniye, Turkey (Türkiye), 34760

Actively Recruiting

92

Research Site

Birmingham, United Kingdom, B4 6NH

Actively Recruiting

93

Research Site

Bristol, United Kingdom, BS2 8BJ

Actively Recruiting

94

Research Site

Liverpool, United Kingdom, L12 2AP

Actively Recruiting

95

Research Site

London, United Kingdom, NW1 2PG

Actively Recruiting

96

Research Site

London, United Kingdom, WC1N 3JH

Actively Recruiting

97

Research Site

Manchester, United Kingdom, M13 9WL

Actively Recruiting

98

Research Site

Southampton, United Kingdom, SO16 6YD

Actively Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants | DecenTrialz